Drug Development Research


ISSN: 0272-4391        年代:1995
当前卷期:Volume 34  issue 1     [ 查看所有卷期 ]

年代:1995
 
     Volume 34  issue 1
     Volume 34  issue 2   
     Volume 34  issue 3   
     Volume 34  issue 4   
     Volume 35  issue 1   
     Volume 35  issue 2   
     Volume 35  issue 3   
     Volume 35  issue 4   
     Volume 36  issue 1   
     Volume 36  issue 2   
     Volume 36  issue 3   
     Volume 36  issue 4   
1. Inhibition of gastric mucosal damage by santonin pretreatment in rats
  Drug Development Research,   Volume  34,   Issue  1,   1995,   Page  1-8

Mohammed M. Al‐Harbi,   Shoeb Qureshi,   Mohammad M. Ahmed,   Muhammad Raza,   Ghulam A. Miana,   Mohammad Afzal,   Arif H. Shah,  

Preview   |   PDF (808KB)

2. Antimuscarinic properties of vamicamide, a novel compound for the treatment of pollakiuria
  Drug Development Research,   Volume  34,   Issue  1,   1995,   Page  9-18

Takao Yamamoto,   Masahiko Matsuo,   Shunji Yamazaki,   Koji Ueshima,   Tadashi Sawada,   Atsuko Furuichi,   Reiko Ozaki,   Misako Nishii,   Shintaro Miura,   Takahiro Kusunoki,   Natsuki Sato,   Yasushi Koibuchi,   Kimio Esumi,   Minoru Ohtsuka,  

Preview   |   PDF (798KB)

3. Sertindole: A limbic selective neuroleptic with potent anxiolytic effects
  Drug Development Research,   Volume  34,   Issue  1,   1995,   Page  19-29

Connie Sánchez,   Jørn Arnt,   Brenda Costall,   Annette M. Domeney,   Elisabeth Kelly,   Robert J. Naylor,  

Preview   |   PDF (815KB)

4. Attenuation of in vivo and in vitro seizure activity using the adenosine agonist, metrifudil
  Drug Development Research,   Volume  34,   Issue  1,   1995,   Page  30-34

Scott E. Krahl,   Loraine M. Treas,   James D. Castle,   Robert F. Berman,  

Preview   |   PDF (420KB)

5. EP1 receptor antagonist blocks the diarrheagenic, but not cytoprotective, actions of a synthetic prostaglandin
  Drug Development Research,   Volume  34,   Issue  1,   1995,   Page  35-38

Thomas H. Lanthorn,   Robert G. Bianchi,   William E. Perkins,  

Preview   |   PDF (371KB)

6. Ganglionic nicotinic acetylcholine receptor activation by the novel agonist ABT‐418
  Drug Development Research,   Volume  34,   Issue  1,   1995,   Page  39-46

Clark A. Briggs,   Marion L. Hughes,   Lisa M. Monteggia,   Tony Giordano,   Diana Donnelly‐Roberts,   Stephen P. Arneric,  

Preview   |   PDF (761KB)

7. Modulation of the discriminative stimulus properties of (−)‐nicotine by diazepam and ethanol
  Drug Development Research,   Volume  34,   Issue  1,   1995,   Page  47-54

David J. B. Kim,   Jorge D. Brioni,  

Preview   |   PDF (669KB)

8. Alzheimer's disease: Tacrine and tacrine metabolite concentrations in plasma and cognitive change
  Drug Development Research,   Volume  34,   Issue  1,   1995,   Page  55-65

Kenneth L. Davis,   Ren‐Kui Yang,   Michael Davidson,   Richard C. Mohs,   Theresa M. Ryan,   James Schmeidler,   Peter J. Knott,   Leon J. Thal,   Elkan R. Gamzu,  

Preview   |   PDF (1079KB)

9. Pharmacological characterization of enantiomers of 8‐thiomethyl‐2‐(di‐n‐propylamino)tetralin, potent and selective 5‐HT1Areceptor agonists
  Drug Development Research,   Volume  34,   Issue  1,   1995,   Page  66-85

Mark M. Foreman,   Ray W. Fuller,   J. David Leander,   David L. Nelson,   David O. Calligaro,   Virginia L. Lucaites,   David T. Wong,   L. Zhang,   James E. Barrett,   John M. Schaus,  

Preview   |   PDF (1719KB)

10. The G‐protein linked receptor factsbook. S. Watson and S. Arkinstall, Academic Press, London, 1994, xiii + 427 pages, $42.00
  Drug Development Research,   Volume  34,   Issue  1,   1995,   Page  86-87

Michael Williams,  

Preview   |   PDF (160KB)

首页 上一页 下一页 尾页 第1页 共12条